{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:32:47Z","timestamp":1772904767851,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Russian Science Foundation","award":["19-75-10030"],"award-info":[{"award-number":["19-75-10030"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The natural limitations of regeneration in the CNS are major problems for the treatment of neurological disorders, including ischaemic brain strokes. Among the approaches being actively developed to inhibit post-ischaemic negative consequences is the delivery of therapeutic genes encoding neuroprotective molecules to the brain. Unfortunately, there are currently no proven and available medicines that contain recombinant human genes for the treatment of ischaemic cerebral stroke. Of particular interest is the development of treatments for patients at risk of ischaemic stroke. In the present study, we propose a proof of concept for the use of an autologous, genetically enriched leucoconcentrate temporally secreting recombinant vascular endothelial growth factor (VEGF), glial-cell-line-derived neurotrophic factor (GDNF) and the neural cell adhesion molecule (NCAM) for the treatment of stroke. In a mini-pig ischaemic stroke model, genetically enriched leucoconcentrate was infused 4 h after surgery (gene therapy in acute phase) or 2 days before stroke modelling (preventive gene therapy). On day 21, after the stroke modelling, the post-ischaemic brain recovery was examined by morphologic and immunofluorescence analysis. The benefits of treating a stroke with genetically enriched leucoconcentrate both for preventive purposes and in the acute phase were confirmed by an improved performance in behavioural tests, higher preservation of brain tissue and positive post-ischaemic brain remodelling in the peri-infarct area. These results suggest that the employment of autologous leucocytes enabling the temporary production of the recombinant therapeutic molecules to correct the pathological process in the CNS may be one of the breakthrough approaches in gene therapy.<\/jats:p>","DOI":"10.3390\/pharmaceutics14102209","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:31:01Z","timestamp":1666053061000},"page":"2209","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model"],"prefix":"10.3390","volume":"14","author":[{"given":"Zufar","family":"Safiullov","sequence":"first","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Izmailov","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-6683","authenticated-orcid":false,"given":"Mikhail","family":"Sokolov","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3789-0284","authenticated-orcid":false,"given":"Vage","family":"Markosyan","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grayr","family":"Kundakchan","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravil","family":"Garifulin","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-1296","authenticated-orcid":false,"given":"Maksim","family":"Shmarov","sequence":"additional","affiliation":[{"name":"The National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Naroditsky","sequence":"additional","affiliation":[{"name":"The National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Logunov","sequence":"additional","affiliation":[{"name":"The National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-4636","authenticated-orcid":false,"given":"Rustem","family":"Islamov","sequence":"additional","affiliation":[{"name":"The Department of Histology, Cytology and Embryology, Kazan State Medical University, 420012 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","first-page":"S7","article-title":"Targeting the ischemic penumbra","volume":"42","author":"Campos","year":"2011","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kuriakose, D., and Xiao, Z. (2020). Pathophysiology and treatment of stroke: Present status and future perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207609"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12975-011-0093-1","article-title":"Intravascular stem cell transplantation for stroke","volume":"2","author":"Auriat","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15283\/ijsc.2014.7.2.63","article-title":"Efficacy and safety of stem cell therapies for patients with stroke: A systematic review and single arm meta-analysis","volume":"7","author":"Jeong","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/138161211795164149","article-title":"Gene therapy as a novel pharmaceutical intervention for stroke","volume":"17","author":"Ooboshi","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnmol.2016.00034","article-title":"Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke","volume":"9","author":"Craig","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_8","unstructured":"Johnston, H., Warner, J.F., Amiel, A.R., Nedoncelle, K., Carvalho, J.E., and R\u00f6ttinger, E. (2021). Whole body regeneration deploys a rewired embryonic gene regulatory network logic. bioRxiv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/17425247.2016.1144588","article-title":"Targeted delivery of growth factors in ischemic stroke animal models","volume":"13","author":"Rhim","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fphar.2018.00111","article-title":"Triple-gene therapy for stroke: A proof-of-concept in vivo study in rats","volume":"9","author":"Sokolov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Markosyan, V., Safiullov, Z., Izmailov, A., Fadeev, F., Sokolov, M., Kuznetsov, M., Trofimov, D., Kim, E., Kundakchyan, G., and Gibadullin, A. (2020). Preventive triple gene therapy reduces the negative consequences of ischemia-induced brain injury after modelling stroke in a rat. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186858"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/1673-5374.290902","article-title":"Gene-modified leucoconcentrate for personalized ex vivo gene therapy in a mini pig model of moderate spinal cord injury","volume":"16","author":"Islamov","year":"2021","journal-title":"Neural. Regen. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Islamov, R., Bashirov, F., Izmailov, A., Fadeev, F., Markosyan, V., Sokolov, M., Shmarov, M., Logunov, D., Naroditsky, B., and Lavrov, I. (2022). New therapy for spinal cord injury: Autologous genetically-enriched leucoconcentrate integrated with epidural electrical stimulation. Cells, 11.","DOI":"10.3390\/cells11010144"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Meli\u00e0-Sorolla, M., Casta\u00f1o, C., Degregorio-Rocasolano, N., Rodr\u00edguez-Esparragoza, L., D\u00e1valos, A., Mart\u00ed-Sistac, O., and Gasull, T. (2020). Relevance of porcine stroke models to bridge the gap from pre-clinical findings to clinical implementation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186568"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wernersson, R., Schierup, M.H., J\u00f8rgensen, F.G., Gorodkin, J., Panitz, F., Staerfeldt, H.-H., Christensen, O.F., Mailund, T., Hornsh\u00f8j, H., and Klein, A. (2005). Pigs in sequence space: A 0.66X coverage pig genome survey based on shotgun sequencing. BMC Genom., 6.","DOI":"10.1186\/1471-2164-6-70"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1177\/0271678X17709185","article-title":"The IMPROVE guidelines (Ischaemia models: Procedural refinements of in vivo experiments)","volume":"37","author":"Alfieri","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0003-9993(94)90161-9","article-title":"Recovery of upper extremity function in stroke patients: The Copenhagen stroke study","volume":"75","author":"Nakayama","year":"1994","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/14712590903307388","article-title":"Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors","volume":"9","author":"Seregin","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_19","first-page":"294","article-title":"Cytokines: Their role in stroke and potential use as biomarkers and therapeutic targets","volume":"5","author":"Doll","year":"2014","journal-title":"Aging Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroscience.2014.04.036","article-title":"The role of the immune system in central nervous system plasticity after acute injury","volume":"283","author":"Giusto","year":"2014","journal-title":"Neuroscience"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2741\/E607","article-title":"Gene delivery with viral vectors for cerebrovascular diseases","volume":"5","author":"Gan","year":"2013","journal-title":"Front. Biosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2005.06.062","article-title":"I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat","volume":"136","author":"Nomura","year":"2005","journal-title":"Neuroscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awl207","article-title":"Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia","volume":"129","author":"Liu","year":"2006","journal-title":"Brain"},{"key":"ref_24","first-page":"8","article-title":"Protective effect of Ad-VEGF-bone mesenchymal stem cells on cerebral infarction","volume":"26","author":"Chen","year":"2016","journal-title":"Turk. Neurosurg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1227\/01.NEU.0000166682.50272.BC","article-title":"Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia","volume":"57","author":"Zhu","year":"2005","journal-title":"Neurosurgery"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/cne.23582","article-title":"Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage","volume":"522","author":"Haller","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.STR.31.8.1958","article-title":"Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: Comparison with [(15)O]H(2)O positron emission tomography","volume":"31","author":"Sakoh","year":"2000","journal-title":"Stroke"},{"key":"ref_28","first-page":"123","article-title":"A new model of focal cerebral ischemia in the miniature pig","volume":"104","author":"Imai","year":"2006","journal-title":"J. Neurosurg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.tips.2015.08.004","article-title":"L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets","volume":"36","author":"Colombo","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000074808","article-title":"Neuroprotection in cerebral ischaemia: Facts and fancies\u2014The need for new approaches","volume":"17","author":"Wahlgren","year":"2004","journal-title":"Cerebrovasc. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1073\/pnas.1017146108","article-title":"Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation","volume":"108","author":"Adams","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/10\/2209\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:45Z","timestamp":1760144145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/10\/2209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["pharmaceutics14102209"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14102209","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}